GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer M. Alexander Otto, PA, MMSc April 16, 2026

https://www.medscape.com/viewarticle/glp-1-ras-may-lower-hysterectomy-risk-endometrial-cancer-2026a1000bxc GLP-1 receptor agonists are associated with a lower risk for hysterectomy in endometrial intraepithelial neoplasia/early-stage endometrial cancer (EIN/EC) when added to standard progestin therapy, according to a propensity score-matched cohort study.